Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome.,Neurogastroenterology & Motility

当前位置： X-MOL 学术 › Neurogastroenterol. Motil. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome.
Neurogastroenterology & Motility ( IF 3.5 ) Pub Date : 2020-04-20 , DOI: 10.1111/nmo.13860
Bani Ahluwalia _{1,

2} , Maria K Magnusson ₁ , Lena Böhn _{2,

3} , Stine Störsrud ₃ , Fredrik Larsson ₂ , Otto Savolainen ₄ , Alastair Ross _{4,

5} , Magnus Simrén _{3,

6} , Lena Öhman _{1,

3}

Affiliation

Aloe barbadensis Mill. (Aloe) with potential prebiotic effects has been suggested to reduce symptoms in patients with irritable bowel syndrome (IBS). We therefore aimed to determine the effects of an Aloe extract on symptoms of IBS, and evaluate whether effects may be mediated by fecal microbiota and metabolites in a randomized, double‐blind, controlled trial.

中文翻译：

随机临床试验：库拉索芦荟的作用。提取物对肠易激综合征患者的症状，粪便微生物群和粪便代谢产物的影响。

芦荟工厂。（芦荟）具有潜在的益生元作用已被建议减少肠易激综合征（IBS）患者的症状。因此，我们旨在确定芦荟提取物对IBS症状的影响，并在一项随机，双盲，对照试验中评估粪便微生物群和代谢产物是否可能介导了这种影响。

更新日期：2020-04-20

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文